Back to Journals » Journal of Inflammation Research » Volume 14

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment [Corrigendum]

Authors Luo M, Lin Y, Liang R, Li Y, Ge L

Received 10 September 2021

Accepted for publication 10 September 2021

Published 14 September 2021 Volume 2021:14 Pages 4601—4602

DOI https://doi.org/10.2147/JIR.S338699



Luo M, Lin Y, Liang R, Li Y, Ge L. J Inflamm Res. 2021;14:4217–4228.

Page 4222, Correlation Between Tumor Microenvironment and Prognosis in HCC section, the text “Based on Teng et al,29 we defined four types of tumor microenvironment: type I (“adaptive immune resistance”, HHLA2 - high TILs +), which lacked HHLA2 and show intermediate or high TIL density, was observed in 77 of the 202 HCC tissues (38.1%); type II (“immunologic ignorance”, HHLA2 - low TILs -), which lacked HHLA2 and showed low TIL density, was observed in 10 cases (5.0%); type III (“intrinsic induction”, HHLA2 - high TILs -), which lacked HHLA2 and showed intermediate or high TIL density, was observed in 26 cases (12.9%); and type IV (“tolerance”, HHLA2 – low TILs +), which lacked HHLA2 and low TIL density, was observed in 89 cases (44.0%)” should read “Based on Teng et al,29 we defined four types of tumor microenvironment: type I (“adaptive immune resistance”, HHLA2 - high TILs +), which expressed high HHLA2 and showed intermediate or high TIL density, was observed in 77 of the 202 HCC tissues (38.1%); type II (“immunologic ignorance”, HHLA2 - low TILs -), which lacked HHLA2 and showed low TIL density, was observed in 10 cases (5.0%); type III (“intrinsic induction”, HHLA2 - high TILs -), which expressed high HHLA2 and showed low TIL density, was observed in 26 cases (12.9%); and type IV (“tolerance”, HHLA2 - low TILs +), which lacked HHLA2 and showed intermediate or high TIL density, was observed in 89 cases (44.0%)”.

The authors apologize for this error.

Read the original article

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.